Recital 8, Regulation (EU) 2026/2024

In forcesince 10 Sep 2026

The Commission concurs with the opinions of the Agency and therefore considers it appropriate to amend the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ to introduce the administrative and minor changes requested by Lanxess Deutschland GmbH.